KRAS and endometrial cancer: Two common mutations that occur in endometrial cancer are in the tumor suppressor Pten and the oncogene K-ras  [4, 5]. K-ras encodes a guanine nucleotide binding protein of 21 kDa that has a central role in the regulation of cell growth and differentiation by transducing signals from activated transmembrane receptors.